Tonsillitis News and Research RSS Feed - Tonsillitis News and Research

Tonsillitis is inflammation of the tonsils. Your tonsils and adenoids are part of your lymphatic system. Your tonsils are in the back of your throat and your adenoids are higher up, behind your nose. They help protect you from infection by trapping germs coming in through your mouth and nose. Sometimes your tonsils and adenoids become infected themselves. Enlarged adenoids can be sore, make it hard to breathe and cause ear problems.
First antigen test for human bocavirus type 1 now available on ArcDia's mariPOC test platform

First antigen test for human bocavirus type 1 now available on ArcDia's mariPOC test platform

ArcDia Ltd. ArcDia International Ltd today announced that the first antigen test for human bocavirus type 1 is now commercially available on ArcDia's mariPOC test platform. [More]
Scientists show how a subset of bacterial cells escape being killed by many antibiotics

Scientists show how a subset of bacterial cells escape being killed by many antibiotics

Scientists have made an important advance in understanding how a subset of bacterial cells escape being killed by many antibiotics. [More]

Scientists progress towards understanding how some bacterial cells escape being killed by antibiotics

Scientists have made an important advance in understanding how a subset of bacterial cells escape being killed by many antibiotics. [More]
Longer reads: Hospice drains Medicare; false Obamacare 'horror stories;' growing up without vaccines

Longer reads: Hospice drains Medicare; false Obamacare 'horror stories;' growing up without vaccines

Hospice patients are expected to die: The treatment focuses on providing comfort to the terminally ill, not finding a cure. To enroll a patient, two doctors certify a life expectancy of six months or less. But over the past decade, the number of "hospice survivors" in the United States has risen dramatically, in part because hospice companies earn more by recruiting patients who aren't actually dying, a Washington Post investigation has found. Healthier patients are more profitable because they require fewer visits and stay enrolled longer (Peter Whoriskey and Dan Keating, 12/26). [More]

FDA approves Lupin Pharmaceuticals' SUPRAX for Oral Suspension

Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has received approval for SUPRAX (Cefixime) for Oral Suspension, 500 mg/5mL from the United States Food and Drugs Administration (FDA). [More]

General practitioners ‘may miss UTI in children’

Family doctors need to lower their threshold of suspicion for urinary tract infection in children, according to UK research. [More]
Tonsillectomy does not lead to unhealthy weight in children

Tonsillectomy does not lead to unhealthy weight in children

Tonsillectomy leads to weight gain in children, but does not increase the likelihood of overweight or obesity, report researchers. [More]

Study finds dramatic increase in acute throat infection admissions in England

The number of children admitted to hospital in England for acute throat infections increased by 76 per cent between 1999 and 2010, according to new research published today in Archives of Disease in Childhood. [More]
Potentially worrisome weight gains following tonsillectomy occur mostly in children under 6

Potentially worrisome weight gains following tonsillectomy occur mostly in children under 6

Potentially worrisome weight gains following tonsillectomy occur mostly in children under the age of 6, not in older children, a study by Johns Hopkins experts in otolaryngology- head and neck surgery shows. [More]
Regular moderate exercise reduces risk of catching cold-like infections

Regular moderate exercise reduces risk of catching cold-like infections

Battling colds and doing (or pledging to do) more exercise are familiar activities for most of us in January. But different levels of exercise can actually significantly increase or decrease your chances of catching a respiratory infection, says Professor Mike Gleeson from Loughborough University. [More]
Probiotics appear to protect against upper respiratory tract infections

Probiotics appear to protect against upper respiratory tract infections

Taking probiotics seems to provide both children and adults with a mild degree of protection against many upper respiratory tract infections (URTI) including the common cold, according to a new systematic review. People who consume probiotics are also less likely to end up taking antibiotics for an upper respiratory infection, the review found. [More]
Micro-organisms hide themselves from immune defences

Micro-organisms hide themselves from immune defences

That micro-organisms have a great capacity to vary their surface structure is well known. It is one of the reasons why it is so difficult to develop vaccines against HIV and malaria, and why new influenza vaccines have to be produced every year. But it seems that these micro-organisms are also able to completely avoid activating a strong immune response in the person attacked. [More]

Appendix and tonsil surgeries before age 20 can increase risk of premature heart attack

The surgical removal of the appendix and tonsils before the age of 20 was associated with an increased risk of premature heart attack in a large population study performed in Sweden. Tonsillectomy increased the risk by 44% (hazard ratio 1.44) and appendectomy by 33% (HR 1.33). [More]
Tonsillectomy increases risk of pediatric obesity

Tonsillectomy increases risk of pediatric obesity

Tonsillectomy is the most common major surgical procedure performed in children. Children who undergo the surgical removal of their tonsils (tonsillectomy), with or without the removal of their adenoids (adenoidectomy), are at increased risk for becoming overweight after surgery, according to new research published in the February 2011 issue of Otolaryngology - Head and Neck Surgery. [More]

Scientist to develop antibiotics for drug-resistant superbugs

Antibiotics can work miracles, knocking out common infections like bronchitis and tonsillitis. But according to the Center for Disease Control, each year 90,000 people in the U.S. die of drug resistant "superbugs" bacteria like Staphylococcus aureus (MRSA), a deadly form of staph infection resistant to normal antibiotics. Although hospital patients are particularly susceptible as a result of open wounds and weakened immune systems, the bacteria can infect anyone. Dr. Micha Fridman of Tel Aviv University's Department of Chemistry is now developing the next generation of antibiotics designed to overcome this kind of bacteria. And the key, he says, is in the bacteria itself. [More]

Victory Pharma acquires assets of MiddleBrook Pharmaceuticals

Victory Pharma, Inc. today announced that it has completed the acquisition of substantially all of the assets of MiddleBrook Pharmaceuticals, Inc.. [More]

Pernix Therapeutics Holdings acquires oral third-generation cephalosporin, CEDAX

Pernix Therapeutics Holdings, Inc. today announced the acquisition of the antibiotic CEDAX® (ceftibuten) from Shionogi Pharma, Inc. [More]
MiddleBrook Pharmaceuticals, DoctorDirectory.com enter into agreement to expand IncreaseRx promotion program

MiddleBrook Pharmaceuticals, DoctorDirectory.com enter into agreement to expand IncreaseRx promotion program

MiddleBrook Pharmaceuticals, Inc. today announced that it has entered into an agreement with DoctorDirectory.com Inc., the Company’s promotion partner for MOXATAG (amoxicillin extended-release) Tablets, 775 mg, to expand its previously announced IncreaseRx® promotion program. [More]
Renhuang Pharmaceuticals' net income for first-quarter of 2010 increases 17.8%

Renhuang Pharmaceuticals' net income for first-quarter of 2010 increases 17.8%

Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines, today announced its financial results for the first quarter ended January 31, 2010. [More]

MiddleBrook Pharmaceuticals full-year 2009 revenues rise 67.7%

MiddleBrook Pharmaceuticals, Inc. today announced its 2009 fourth quarter and full-year results, that it is further restructuring to reduce expenses, and that it is evaluating strategic alternatives to maximize shareholder value. [More]